Traumatic brain injury

Trauma: Emergency Resuscitation, Perioperative Anesthesia, Surgical Management

Volumn 1, Issue , 2007, Pages 433-446

  Atkins, Gus G ^a   Drummond, John C ^b  

^a UCSD MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 83355178229     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (91)

1. DeWitt DS, Prough DS, Taylor CL, Whitley JM. Reduced cerebral blood flow, oxygen delivery, and electroencephalographic activity after traumatic brain injury and mild hemorrhage in cats. J Neurosurg 1992; 76:812-821.
2. Marmarou A, Anderson RL, Ward JD, et al. Impact of ICP instability and hypotension on outcome in patients with severe head trauma. J Neurosurg 1991; 75:S59-S66.
3. Chesnut RM, Marshall LF, Klauber MR, et al. The role of secondary brain injury in determining outcome from severe head injury. J Trauma 1993; 34:216-222.
4. Marshall LF, Toole BM, Bowers SA. The National Traumatic Coma Data Bank. Part 2: Patients who talk and deteriorate: Implications for treatment. J Neurosurg 1983; 59:285-288.
5. Criswell JC, Parr MJ, Nolan JP. Emergency airway management in patients with cervical spine injuries. Anaesthesia 1994; 49:900-903.
6. Stene JD. Anesthesia for the critically ill trauma patient. In: Siegel JH, ed. Trauma: Emergency Surgery and Critical Care. Melbourne: Churchill Livingstone, 1987:843-862.
7. Kirschenbaum KJ, Nadimpalli SR, Fantus R, Cavallino RP. Unsuspected upper cervical spine fractures associated with significant head trauma: Role of CT. J Emerg Med 1990; 8:183-198.
8. Sloan TB. Anesthetics and the Brain. Anesthesiology Clin N Am 2002; 20:265-292.
9. Grounds RM, Twigley AJ, Carli F, et al. The haemodynamic effects of intravenous induction. Comparison of the effects of thiopentone and propofol. Anaesthesia 1985; 40:735-740.
10. Levy ML, Aranda M, Zelman V, et al. Propylene glycol toxicity following continuous etomidate infusion for the control of refractory cerebral edema. Neurosurgery 1995; 37:363-369.
11. Weiskopf RB, Bogetz MS, Roizen MF, et al. Cardiovascular and metabolic sequelae of inducing anesthesia with ketamine or thiopental in hypovolemic swine. Anesthesiology 1984; 60:214-219.
12. Todd MM, Warner DS, Sokoll MD, et al. A prospective comparative trial of three anesthetics for elective supratentorial craniotomy. Anesthesiology 1993; 78:1005-1020.
13. Stevenson PH, Birch AA. Succinylcholine-induced hyperkalemia in a patient with a closed head injury. Anesthesiology 1979; 51:89-90.
14. Frankville DD, Drummond JC. Hyperkalemia after succinylcholine administration in a patient with closed head injury without paresis. Anesthesiology 1987; 67:264-266.
15. Gronert GA. Cardiac arrest after succinylcholine. Anesthesiology 2001; l94:523-529.
16. Markewitz BA, Elstad MR. Succinylcholine-induced hyperkalemia following prolonged neuromuscular blockade. Chest 1997; 111:248-250.
17. Sato K, Nishiwaki K, Kuno N. Unexpected hyperkalemia following succinylcholine administration in prolonged immobilized parturients treated with magnesium and ritodrine. Anesthesiology 2000; 93(6):1539-1541.
18. Kovarik DW, Mayberg TS, Lam AM, et al. Succinylcholine does not change intracranial pressure, cerebral blood flow velocity, or the electroencephalogram in patients with neurologic injury. Anesth Analg 1994; 78:469-473.
19. Stirt JA, Grosslight KR, Bedford RF, Vollmer D. “Defasciculation” with metocurine prevents succinylcholine-induced increases in intracranial pressure. Anesthesiology 1987; 67:50-53.
20. Pietropaoli JA, Rogers FB, Shackford SR, et al. The deleterious effects of intraoperative hypotension on outcome in patients with severe head injuries. J Trauma 1992; 33:403-407.
21. Jones PA, Andrews PJ, Midgley S, et al. Measuring the burden of secondary insults in head-injured patients during intensive care. J Neurosurg Anesthesiol 1994; 6:4-14.
22. Stocchetti N, Furlan A, Volta F. Hypoxemia and arterial hypotension at the accident scene in head injury. J Trauma 1996; 40:764-767.
23. Bouma GJ, Muizelaar JP, Choi SC, et al. Cerebral circulation and metabolism after severe traumatic brain injury: the elusive role of ischemia. J Neurosurg 1991; 75:685-693.
24. Bouma GJ, Muizelaar JP, Stringer WA, et al. Ultra-early evaluation of regional cerebral blood flow in severely head-injured patients using xenon-enhanced computerized tomography. J Neurosurg 1992; 77:360-368.
25. Brown JIM, Moulton RJ, Konasiewicz SJ, Baker AJ. Cerebral oxidative metabolism and evoked potential deterioration after severe brain injury: new evidence of early posttraumatic ischemia. Neurosurgery 1998; 42:1057-1064.
26. DeWitt DS, Prough DS, Taylor CL, et al. Regional cerebrovascular responses to progressive hypotension after traumatic brain injury in cats. Am J Physiol 1992; 163:H1276-H1284.
27. Romner B, Bellner J, Kongstad P, Sjoholm H. Elevated transcranial Doppler flow velocities after severe head injury: cerebral vasospasm or hyperemia? J Neurosurg 1996; 85:90-97.
28. Steiger HJ, Ciessinna E, Seiler RW. Identification of posttraumatic ischemia and hyperperfusion by determination of effect of induced arterial hypertension on carbon dioxide reactivity. Stroke 1996; 27:2048-2051.
29. Kelly DF, Kordestani RK, Martin NA, et al. Hyperemia following traumatic brain injury: relationship to intracranial hypertension and outcome. J Neurosurg 1996; 85:762-771.
30. Kelly DF, Martin NA, Kordestani R, et al. Cerebral blood flow as a predictor of outcome following traumatic brain injury. J Neurosurg 1997; 86:633-641.
31. Martin NA, Patwardhan RV, Alexander MJ, et al. Characterization of cerebral hemodynamic phases following severe head trauma: hypoperfusion, hyperemia, and vasospasm. J Neurosurg 1997; 87:9-19.
32. Marion DW, Darby J, Yonas H. Acute regional cerebral blood flow changes caused by severe head injuries. J Neurosurg 1991; 74:407-414.
33. Martin NA, Doberstein C, Zane C, et al. Posttraumatic cerebral arterial spasm: transcranial Doppler ultrasound, cerebral blood flow, and angiographic findings. J Neurosurg 1992; 77:575-583.
34. Bouma GJ, Muizelaar JP, Bandoh K, Marmarou A. Blood pressure and intracranial pressure-volume dynamics in severe head injury: relationship with cerebral blood flow. J Neurosurg 1992; 77:15-19.
35. Chan K-H, Miller JD, Dearden NM, et al. The effect of changes in cerebral perfusion pressure upon middle cerebral artery blood flow velocity and jugular bulb venous oxygen saturation after severe brain injury. J Neurosurg 1992; 77:55-61.
36. Chan KH, Dearden NM, Miller JD, et al. Multimodality monitoring as a guide to treatment of intracranial hypertension after severe brain injury. Neurosurgery 1993; 32:547-553.
37. Rosner MJ, Daughton S. Cerebral perfusion pressure management in head injury. J Trauma 1990; 30:933-941.
38. Robertson CS, Valadka AB, Hannay HJ, et al. Prevention of secondary ischemic insults after severe head injury. Crit Care Med 1999; 27:2086-2095.
39. Juul N, Morris GF, Marshall SB, et al. Intracranial hypertension and cerebral perfusion pressure: Their influence on neurological deterioration and outcome in severe head injury. J Neurosurg 2000; 92:1-6.
40. Howells T, Elf K, Jones PA, et al. Pressure reactivity as a guide in the treatment of cerebral perfusion pressure in the treatment of patients with brain trauma. J Neurosurg 2005; 102:311-317.
41. Coles JP, Fryer TD, Smielewski P. Incidence and mechanisms of cerebral ischemia in early clinical head injury. J Cereb Blood Flow Metabol 2004; 24:202-211.
42. Asgeirsson B, Grande P-O, Nordstrom C-H. The Lund concept of post-traumatic brain oedema therapy. Acta Anaesthesiol Scand 1995; 39:103-106.
43. Tommasino C, Moore S, Todd MM. Cerebral effects of isovolemic hemodilution with crystalloid or colloid solutions. Crit Care Med 1988; 16:862-868.
44. Kaieda R, Todd MM, Warner DS. Prolonged reduction in colloid oncotic pressure does not increase brain edema following cryogenic injury in rabbits. Anesthesiology 1989; 71:554-560.
45. Drummond JC, Patel PM, Cole DJ, Kelly PJ. The effect of reduction of colloid oncotic pressure, with and without reduction of osmolality, on post traumatic cerebral edema. Anesthesiology 1998; 88:993-1002.
46. Gunnar W, Jonasson O, Merlotti G, et al. Head injury and hemorrhagic shock: Studies of the blood brain barrier and intracranial pressure after resuscitation with normal saline solution, 3% saline solution, and dextran-40. Surgery 1988; 103:398-407.
47. Ogden AT, Mayer SA, Connolly, ES. Hyperosmolar agents in neurosurgical practice: the evolving role of hypertonic saline. Neurosurgery 2005; 57:207-215.
48. Stump DC, Strauss RG, Henriksen RA, et al. Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII. Transfusion 1985; 25:349-354.
49. Conroy JM, Fishman RL, Reeves ST, et al. The effects of desmopressin and 6% hydroxyethyl starch on factor VIII:C. Anesth Analg 1996; 83:804-807.
50. Treib J, Haass A, Schimrigk K. European hydroxyethyl starch: a safe and inexpensive alternative to albumin. [letter]. Anesth Analg 1997; 85:709.
51. Treib J, Haass A. Hydroxyethyl starch. [letter]. J Neurosurg 1997; 86:574-575.
52. London MJ, Ho JS, Triedman JK, et al. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. J Thorac Cardiovasc Surg 1989; 97:785-797.
53. Zygun DA, Steiner LA, Johnston AJ, et al. Hyperglycemia and brain tissue pH after traumatic brain injury. Neurosurgery 2004; 55:877-882.
54. Newell DW, Weber JP, Watson R, et al. Effect of transient moderate hyperventilation on dynamic cerebral autoregulation after severe head injury. Neurosurgery 1996; 39:35-44.
55. Muizelaar JP, Marmarou A, Ward JD, et al. Adverse effects of prolonged hyperventilation in patients with severe head injury: A randomized clinical trial. J Neurosurg 1991; 75:731-739.
56. Yoshida K, Marmarou A. Effects of tromethamineand hyperventilation on brain injury in the cat. J Neurosurg 1991; 74:87-96.
57. Sutton LN, McLaughlin AC, Dante S, et al. Cerebral venous oxygen content as a measure of brain energy metabolism with increased intracranial pressure and hyperventilation. J Neurosurg 1990; 73:927-932.
58. Andrews RJ, Muto RP. Retraction brain ischaemia: cerebral blood flow, evoked potentials, hypotension and hyperventilation in a new animal model. Neurol Res 1992; 14:19-25.
59. McLaughlin MR, Marion DW. Cerebral blood flow and vasoresponsivity within and around cerebral contusions. J Neurosurg 1996; 85:871-876.
60. Stocchetti N, Maas AIR, Chieregato A, vanderPlas AA. Hyperventilation in head injury: A review. Chest 2005; 127:1812-1827.
61. Safwat AM, Daniel D. Grand mal seizure after fentanyl administration (letter). Anesthesiology 1983; 59:78.
62. Gopinath SP, Robertson CS, Contant CF, et al. Jugular venous desaturation and outcome after head injury. J Neurol Neurosurg Psychiatry 1994; 57:717-723.
63. Cold GE. Does acute hyperventilation provoke cerebral oligaemia in comatose patients after acute head injury? Acta Neurochir 1989; 96:100-106.
64. Miller JD, Dearden NM, Piper IR, Chan KH. Control of intracranial pressure in patients with severe head injury. Journal of Neurotrauma 1992; 9:S317-S326.
65. Matta BF, Lam AM, Mayberg TS, et al. A critique of the intraoperative use of jugular venous bulb catheters during neurosurgical procedures. Anesth Analg 1994; 79:745-750.
66. Schell RM, Cole DJ. Cerebral monitoring: jugular venous oximetry. Anesth Analg 2000; 90:559-566.
67. White H, Baker A. Continuous jugular venous oximetry in the neurointensive care unit: a brief review. Can J Anaesth 2002; 49:623-629.
68. McLeod AD, Igielman F, Elwell C, et al. Measuring cerebral oxygenation during normobaric hyperoxia: A comparison of tissue microprobes, near-infrared spectroscopy, and jugular venous oximetry in head injury. Anesth Analg 2003; 97:851-856.
69. Clifton GL, Jiang JY, Lyeth BG, et al. Marked protection by moderate hypothermia after experimental traumatic brain injury. J Cereb Blood Flow Metab 1991; 11:114-121.
70. Shiozaki T, Sugimoto H, Taneda M, et al. Effect of mild hypothermia on uncontrollable intracranial hypertension after severe head injury. J Neurosurg 1993; 79:363-368.
71. Marion DW, Obrist WD, Carlier PM, et al. The use of moderate therapeutic hypothermia for patients with severe head injuries: a preliminary report. J Neurosurg 1993; 79:354-362.
72. Clifton GL, Allen S, Barrodale P, et al. A phase II study of moderate hypothermia in severe brain injury. J Neurotrauma 1993; 10:263-273.
73. Metz C, Holzschuh M, Bein T, et al. Moderate hypothermia in patients with severe head injury: cerebral and extracerebral effects. J Neurosurg 1996; 85:533-541.
74. Tateishi A, Soejima Y, Taira Y, et al. Feasibility of the titration method of mild hypothermia in severely head-inured patients with intracranial hypertension. Neurosurgery 1998; 42:1065-1070.
75. Clifton GL, Miler ER, Choi SC, et al. Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med 2001; 344:556-563.
76. Tolias CM, Bullock MR. Critical appraisal of neuroprotective trials in head injury: what have we learned? Neuro Rxw 2004; 1:71-79.
77. Young B, Runge JW, Waxman KS, et al. Effects of pegorgotein on neurologic outcome of patients with severe head injury. A multicenter, randomized controlled trial. JAMA 1996; 276:538-543.
78. Davis SM, Albers GW, Diener H, et al. Termination of acute stroke studies involving selfotel treatment. Lancet 1997; 349:32.
79. Tsuchida E, Bullock R. The effect of the glycine site-specific Nmethyl-D-aspartate antagonist ACEA1021 on ischemic brain damage caused by acute subdural hematoma in the rat. J Neurotrauma 1995; 12:279-288.
80. Di X, Bullock R, Watson J, et al. Effect of CP101,606, a novel NR2B subunit antagonist of the N-methyl-D-aspartate receptor, on the volume of ischemic brain damage and cytotoxic brain edema after middle cerebral artery occlusion in the feline brain. Stroke 1997; 28:2244-2251.
81. Marshall LF, Maas AIR, Marshall SB, et al. A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury. J Neurosurg 1998; 89:519-525.
82. Harders A, Kakarieka A, Braakman R, The German SAH Study Group. Traumatic subarachnoid hemorrhage and its treatment with nimodipine. J Neurosurg 1996; 85:82-89.
83. Langham J, Goldfrad C, Teasdale G, et al. Calcium channel blockers for acute traumatic brain injury. Cochrane Database Syst Rev 2003; (4):CD000565.
84. Grumme T, Baethmann A, Kolodziejczyk D, et al. Treatment of patients with severe head injury by triamcinolone: a prospective, controlled multicenter clinical trial of 396 cases. Res Exp Med 1995; 195:217-229.
85. The CRASH Trial Collaborators. Effect of intravenous corticosteroids on death within 14 days in 10,008 adults with clinically significant head injury. Lancet 2004; 364:1321-1328.
86. Marmarou A, Nichols J, Burgess J, et al., American Brain Injury Consortium Study Group. Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: results of a multi-center, randomized, placebo-controlled trial. J Neurotrauma 1999; 16:431-444.
87. Alves OL, Doyle A, Gilman C, Sarkar M, Young HF, Bullock R. Evaluation of topiramate neuroprotective effect in severe TBI by using microdialysis. J Neurosurg 2003; 98:712 (Abstract of oral presentation at AANS Meeting, San Diego, 2003.).
88. Knoller N, Levi L, Shoshan I, et al. Dexanabinol (HU-211) in the treatment of severe closed head injury: a randomized, placebocontrolled, phase II clinical trial. Crit Care Med 2002; 30:548-554.
89. Mauler F, Mittendorf J, Horvath E, De Vry J. Characterization of the diarylether sulfonylester (-)-(R)-3-(2-hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties. J Pharmacol Exp Ther 2002; 302:359-368.
90. Fumoto N, Nakatsuka H, Ohta S, Kumon Y, Ohnishi T. Hippocampal CA1 neuron survival and cytosolic FKBP12, the 12 kDa FK506-binding protein, after ischemia and tacrolimus treatment in gerbils. Neurosci Lett 2003; 339:219-222.
91. Jackson PF, Tays KL, Maclin KM, et al. Design and pharmacological activity of phosphinic acid based NAALADase inhibitors. J Med Chem 2001; 44:4170-4175.